TG Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of TGTX for the last quarter is 83.88 M USD, and it's 14.17% higher compared to the previous quarter. The net income of Q3 24 is 3.88 M USD.